Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease. - Wikidata - awgldk - TriplyDB

Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease.

Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease.

http://www.wikidata.org/entity/Q46418067

about

P2Y12-ADP receptor antagonists: Days of future and past The Role of Mean Platelet Volume as a Predictor of Mortality in Critically Ill Patients: A Systematic Review and Meta-Analysis Ticagrelor: Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Profile: An Update State-of-the-Art: Hypo-responsiveness to oral antiplatelet therapy in patients with type 2 diabetes mellitus.Pak2 restrains endomitosis during megakaryopoiesis and alters cytoskeleton organization.Detection and quantification of circulating immature platelets: agreement between flow cytometric and automated detection.Flow cytometric analysis of platelet cyclooxygenase-1 and -2 and surface glycoproteins in patients with immune thrombocytopenia and healthy individuals.Platelet turnover predicts outcome after coronary intervention.Decline in mean platelet volume in patients with patent foramen ovale undergoing percutaneous closure Do immature platelet levels in chest pain patients presenting to the emergency department aid in the diagnosis of acute coronary syndrome?Mean platelet volume (MPV) predicts middle distance running performance Platelet function in patients with diabetes mellitus: from a theoretical to a practical perspective Variability and persistence of aspirin response in lower extremity peripheral arterial disease patients The relationship between diabetes, metabolic syndrome, and platelet activity as measured by mean platelet volume: the National Health And Nutrition Examination Survey, 1999-2004.Relationship Between Insulin Resistance and Mean Platelet Volume in Gestational Diabetes Mellitus Drug-Free Platelets Can Act as Seeds for Aggregate Formation During Antiplatelet Therapy.Gradual increase in thrombogenicity of juvenile platelets formed upon offset of prasugrel medication.Disordered haematopoiesis and athero-thrombosis.Mean platelet volume and prevalence of peripheral artery disease, the National Health and Nutrition Examination Survey, 1999-2004.Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis.Clinical marker of platelet hyperreactivity in diabetes mellitus.Platelet turnover in stable coronary artery disease - influence of thrombopoietin and low-grade inflammation.Comparison of mean platelet volume in type 2 diabetics on insulin therapy and on oral hypoglycaemic agents.Relation of CYP2C19 loss-of-function polymorphism to the occurrence of stent thrombosis.Aldose reductase-mediated phosphorylation of p53 leads to mitochondrial dysfunction and damage in diabetic platelets.Antithrombotic therapy in patients with diabetes mellitus and coronary artery disease.Glycoprotein IIb-IIIa content and platelet aggregation in healthy volunteers and patients with acute coronary syndrome.Antiplatelet drug therapy: role of pharmacodynamic and genetic testing.Mean platelet volume/platelet count ratio as a predictor of long-term mortality after non-ST-elevation myocardial infarction.Genetic and non-genetic factors affecting the response to clopidogrel therapy.Pharmacokinetic, pharmacodynamic and pharmacogenetic profile of the oral antiplatelet agent ticagrelor.Overcoming aspirin treatment failure in diabetes.Biomarkers in acute coronary artery disease.Platelet function profiles in patients with diabetes mellitus.Dual antiplatelet therapy in patients with diabetes mellitus: special considerations.Exploring the potential of platelet proteomics in children.Do methodological differences account for the current controversy on tissue factor expression in platelets?Association between cell-derived microparticles and adverse events in patients with nonpulsatile left ventricular assist devices.Newly Formed Reticulated Platelets Undermine Pharmacokinetically Short-Lived Antiplatelet Therapies.New roles for mean platelet volume measurement in the clinical practice?

P2860

Q26745619-92240F76-C9DE-4C43-9018-7FDE116B8702 Q26766340-5A858EAA-C54C-465D-B0A3-D9B8A65BC696 Q27006031-9EE93521-5222-4747-8DDC-1D0D55B754EA Q30373414-A462A20C-D18F-495A-8FD2-E2F7004A594A Q33421593-D197A40F-EB6E-4369-BC4D-54234DA8BDD2 Q33429675-33485547-1D72-42DF-86C1-FEC9B9CA21DE Q33435826-D36504B8-94F1-4275-92CC-5F79A95D98B6 Q33721709-D71B3438-5331-4E8A-A903-785BD394C93C Q34219702-1EAE2419-4E51-4227-AE42-C3B18E68DFE0 Q34475551-1502DE82-D3E6-4A93-A79E-A0A8366B6906 Q34490156-59C14AFB-7D12-4D5C-A514-320EF61BA227 Q35174193-BE228E99-DC69-49F8-BBB5-CFE0EDECAEF6 Q35400988-E925FF07-7FB5-412E-98E3-E94E8EAE053C Q35898176-FA7ED150-6304-4AC4-9CAF-D42BD1A57A6B Q36026025-5C4B008C-975E-4D5E-B71D-C190DFE1326B Q36104404-0A27BA14-EB88-423C-9AB3-423E73AC27E4 Q36709028-1B3BDA02-D2B1-417F-B2F6-7436A563B0C6 Q36773876-2D70D7AB-BEED-4CA4-94D9-A7F975A61CC3 Q37084956-805F734F-1B93-4062-8324-DFCC0A3BBA12 Q37127450-47DEC58C-1E62-491C-9A21-63FA758D186A Q37435694-337AE2B6-DA99-431A-96F1-68E12ED03EDA Q37499510-BCC21216-E4C6-44F5-AA68-70A1A2FEEEE5 Q37573348-0B175702-DA09-43BB-9221-8C0F78EF42E3 Q37693951-60A7B708-7D50-4D91-BB66-3D00659D5AB7 Q37707000-7B58B99E-6DEF-4FE4-8CA9-6AEA7EDA2806 Q37797795-FFDD7799-DDCA-44DE-AE1D-E7A0CA0A6A77 Q37844150-28685C9E-2D57-4DA2-8EB0-2D202E047171 Q37882712-B911125D-6DD5-497A-BEA7-425FBAD95CFB Q37895699-2A305D2F-483A-40EB-B862-18D1CD3AF0C8 Q37991382-6824023A-4029-42E8-98CF-779FD53DA339 Q38001453-4B8916C7-4DB8-48C3-BB7E-05A4D7E3776D Q38055245-F398CDC5-5AC1-45E5-94D7-CD7245C678BA Q38059154-42CC4C1A-FED3-450B-9223-4D0682943A40 Q38081078-07BF9D2D-7C2C-42F5-8950-796B827ACE26 Q38087381-2B57F143-17EA-4437-857E-223B8FADACDB Q38236744-DE6E95AC-725C-4670-A4CD-C3760B976066 Q38712560-8CDB787B-7196-4200-8C74-1D8D07720C26 Q38834342-09475C0D-4C3B-4B36-B4D2-E25534A84AAB Q38916487-92D3C036-5157-4B0C-BC7B-93D3FF287617 Q38967998-E86D0815-8498-483C-A76F-BCC9FBCED9EE

P2860

Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease.

http://www.wikidata.org/entity/Q46418067

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Role of reticulated platelets ...... table coronary artery disease.

@en

Role of reticulated platelets ...... table coronary artery disease.

@nl

type

label

Role of reticulated platelets ...... table coronary artery disease.

@en

Role of reticulated platelets ...... table coronary artery disease.

@nl

prefLabel

Role of reticulated platelets ...... table coronary artery disease.

@en

Role of reticulated platelets ...... table coronary artery disease.

@nl

P1433

Q46418067-30E86469-7C46-449D-9D7F-728A73E63EE0

P1476

Q46418067-28010385-88EE-45ED-B3A6-5FA8BA93DE4C

P2093

Q46418067-019F8C18-6F77-4834-9C03-94DA496DF092

Q46418067-07840C2D-4E46-44D7-A205-894513586638

Q46418067-3DAB9933-3E3F-405C-8773-8946CF74FC58

Q46418067-479C74F6-ADB6-4B00-8B91-27DE80031534

Q46418067-6AA2356F-AC6D-4BA2-862B-ED4255D89AD4

Q46418067-87C2BF8F-9376-4DBB-BD4A-3AA577ECA370

Q46418067-96912EC1-4210-4EBE-887D-36D6B8FEF3BE

Q46418067-C680FBCB-20E4-4940-B7C6-8731C489E549

Q46418067-F93AEAE8-7B72-46F9-8288-05C79378DB2B

Q46418067-FD109D8C-4302-42BD-894D-E923C6EE96EA

P304

Q46418067-306E16EC-7F90-411B-A213-C1DD7FE6B8DD

P31

Q46418067-D4A0F449-2E98-4BE7-B85B-7E597EEB3BC4

P356

Q46418067-F4BC48E0-F331-43DE-A023-205AC7000573

P407

Q46418067-6E74FF4E-E405-4E2E-BD7A-C6C4A417C3D2

P433

Q46418067-E134A384-22E0-4DE4-BE7A-0BEBFD84A3B8

P478

Q46418067-E7ADFD59-A934-426B-A2DA-01982AB19423

P577

Q46418067-8EFD0B7B-1C12-419D-863D-E63CB2DE5488

P5875

Q46418067-CC397E6A-6696-4E61-83ED-47FA1080C8C4

P698

Q46418067-FE40B844-C87C-477F-AEA0-6DACCB15EABF

P921

Q46418067-3B417AC9-338F-45A2-819E-2AE2742FC1CE

Q46418067-9E8AEED1-DCA8-44C9-9B2D-C4BAD150B1D8

Q46418067-C49B4E6E-BD61-41DB-A656-E22DF47F6A69

P356

J.JACC.2008.05.031

P1433

Journal of the American College of Cardiology

P1476

Role of reticulated platelets ...... table coronary artery disease.

@en

P2093

Armando Tellez

http://www.w3.org/2001/XMLSchema#string

Carlos L Alviar

http://www.w3.org/2001/XMLSchema#string

Eli I Lev

http://www.w3.org/2001/XMLSchema#string

Jing-Fei Dong

http://www.w3.org/2001/XMLSchema#string

Juan F Granada

http://www.w3.org/2001/XMLSchema#string

Mehmet Arikan

http://www.w3.org/2001/XMLSchema#string

Muthiah Vaduganathan

http://www.w3.org/2001/XMLSchema#string

Neal S Kleiman

http://www.w3.org/2001/XMLSchema#string

Sasidhar Guthikonda

http://www.w3.org/2001/XMLSchema#string

Timothy DeLao

http://www.w3.org/2001/XMLSchema#string

P304

743-749

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACC.2008.05.031

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P577

2008-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23185481

http://www.w3.org/2001/XMLSchema#string

P698

18718422

http://www.w3.org/2001/XMLSchema#string

P921